Special Edition: Meeting demand for viral vectors Polyplus launches transfection reagent for large scale viral vector production 18-Aug-2021 By Jane Byrne Recombinant adeno-associated viruses (rAAVs) are becoming the vector of choice for delivering gene therapies, says the French firm.